Galectin Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 2.29 M | $9.52 B | 1.82% | 3.56% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 1.09 M | $4.54 M | -10.95% | 1.70% |
| BLACKROCK, INC. | 02/12/2026 | 796.56 K | $3.31 M | -0.14% | 1.24% |
| MARSHALL WACE, LLP | 02/13/2026 | 602.13 K | $2.50 M | 8.64% | 0.94% |
| WEALTHSPIRE ADVISORS, LLC | 02/13/2026 | 601.97 K | $2.50 M | 25.54% | 0.94% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 598.07 K | $2.49 B | -5.53% | 0.93% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 515.60 K | $2.14 M | 889.64% | 0.80% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/12/2026 | 334.10 K | $1.39 M | 13.29% | 0.52% |
| LPL FINANCIAL LLC | 02/11/2026 | 325.26 K | $1.35 M | -9.72% | 0.51% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 307.23 K | $1.28 B | 1,295.61% | 0.48% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 286.92 K | $1.19 M | -35.75% | 0.45% |
| MORGAN STANLEY | 02/13/2026 | 279.29 K | $1.16 M | 22.32% | 0.44% |
| GENEOS WEALTH MANAGEMENT INC. | 01/28/2026 | 243.33 K | $1.01 M | -32.44% | 0.38% |
| STATE STREET CORP | 02/13/2026 | 242.23 K | $1.01 M | 5.16% | 0.38% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 235.51 K | $979.71 K | 113.28% | 0.37% |
| SOVRAN ADVISORS, LLC | 01/20/2026 | 225.87 K | $711.50 K | 43.50% | 0.35% |
| VIVALDI CAPITAL MANAGEMENT LP | 02/13/2026 | 204.07 K | $848.93 K | -20.21% | 0.32% |
| JANE STREET GROUP, LLC | 02/12/2026 | 199.34 K | $829.25 M | 1,258.27% | 0.31% |
| RETIREMENT GUYS FORMULA LLC | 01/23/2026 | 184.56 K | $767.78 K | 11.19% | 0.29% |
| JANE STREET GROUP, LLC | 02/12/2026 | 180.30 K | $750.05 M | 100.00% | 0.28% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/05/2026 | 126.02 K | $524.00 K | 3.97% | 0.20% |
| BARCLAYS PLC | 02/13/2026 | 106.40 K | $442.63 K | 100.00% | 0.17% |
| BELPOINTE ASSET MANAGEMENT LLC | 01/27/2026 | 106.14 K | $441.54 K | 100.00% | 0.17% |
| FORTIS CAPITAL ADVISORS, LLC | 01/27/2026 | 106.14 K | $441.54 K | 100.00% | 0.17% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 101.97 K | $424.00 K | 17.08% | 0.16% |
| TRAYNOR CAPITAL MANAGEMENT, INC. | 01/12/2026 | 101.60 K | $422.66 K | 2.52% | 0.16% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 88.38 K | $367.64 K | 0.00% | 0.14% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 79.10 K | $329.06 K | 14.64% | 0.12% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 78.15 K | $325.08 K | 427.08% | 0.12% |
| TRUIST FINANCIAL CORP | 02/02/2026 | 68.00 K | $282.88 K | 0.00% | 0.11% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 63.20 K | $262.91 K | 100.00% | 0.10% |
| XTX TOPCO LTD | 02/17/2026 | 51.94 K | $216.05 K | 100.00% | 0.08% |
| HORIZON KINETICS ASSET MANAGEMENT LLC | 02/11/2026 | 51.48 K | $214.17 K | -4.20% | 0.08% |
| SANCTUARY ADVISORS, LLC | 01/29/2026 | 45.79 K | $190.47 K | -9.49% | 0.07% |
| UBS GROUP AG | 01/29/2026 | 39.10 K | $162.67 K | 24.08% | 0.06% |
| BLAIR WILLIAM & CO/IL | 02/17/2026 | 37.88 K | $157.60 M | 0.00% | 0.06% |
| LIDO ADVISORS, LLC | 02/10/2026 | 36.33 K | $153.85 K | 0.00% | 0.06% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 01/08/2026 | 35.22 K | $121.50 K | -0.06% | 0.05% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 29.99 K | $124.74 K | -33.35% | 0.05% |
| CITADEL ADVISORS LLC | 02/17/2026 | 27.50 K | $114.40 M | -61.96% | 0.04% |
| SOLUTIONS 4 WEALTH, LTD | 02/09/2026 | 25.38 K | $105.57 K | 0.00% | 0.04% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 25.06 K | $104.26 M | -1.04% | 0.04% |
| INSPIRE ADVISORS, LLC | 02/13/2026 | 21.10 K | $87.76 K | 0.00% | 0.03% |
| CAHABA WEALTH MANAGEMENT, INC. | 01/07/2026 | 21.00 K | $87.36 K | 0.00% | 0.03% |
| MARINER, LLC | 02/13/2026 | 19.91 K | $82.81 K | -27.80% | 0.03% |
| STRATOS WEALTH PARTNERS, LTD. | 01/20/2026 | 19.09 K | $79.41 K | -36.48% | 0.03% |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | 02/17/2026 | 18.90 K | $78.62 K | 100.00% | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 16.61 K | $69.11 K | -0.21% | 0.03% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 16.46 K | $68.48 K | 100.00% | 0.03% |
| JEFFERIES FINANCIAL GROUP INC. | 02/09/2026 | 16.44 K | $68.37 K | -5.00% | 0.03% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Galectin Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 117 institutional investors and hedge funds held shares of Galectin Therapeutics Inc. The most heavily invested institutionals were:
VANGUARD GROUP INC: 2.29 M
ADVISOR GROUP HOLDINGS, INC.: 1.09 M
BlackRock, Inc.: 796,558
MARSHALL WACE, LLP: 602,134
Wealthspire Advisors, LLC: 601,973
GEODE CAPITAL MANAGEMENT, LLC: 598,074
13.84% of Galectin Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 13.93 M shares in the last 24 months. This purchase volume represents approximately $40.80 M in transactions.